From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151

Bioorg Med Chem Lett. 2012 Apr 15;22(8):2963-7. doi: 10.1016/j.bmcl.2012.01.125. Epub 2012 Feb 8.

Abstract

The discovery, synthesis and biological evaluation of a novel series of 7-isoxazoloquinolines is described. Several analogs are shown to increase ApoA1 expression within the nanomolar range in the human hepatic cell line HepG2.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Apolipoprotein A-I / metabolism*
  • Drug Discovery*
  • Hep G2 Cells
  • Heterocyclic Compounds, 4 or More Rings / chemistry*
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Histone Acetyltransferases
  • Histone Chaperones
  • Humans
  • Inhibitory Concentration 50
  • Mice
  • Mice, Inbred BALB C
  • Nerve Tissue Proteins
  • Nuclear Proteins / antagonists & inhibitors*
  • Nuclear Proteins / metabolism
  • Quinolines / chemistry*
  • Quinolines / pharmacology
  • Rats
  • Structure-Activity Relationship
  • Up-Regulation / drug effects*

Substances

  • Anti-Inflammatory Agents
  • Apolipoprotein A-I
  • BRD1 protein, rat
  • GSK1210151A
  • Heterocyclic Compounds, 4 or More Rings
  • Histone Chaperones
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • Quinolines
  • quinoline
  • BRD1 protein, human
  • Histone Acetyltransferases